Chengdu Kanghong Pharmaceuticals Group Co Ltd Financial Flexibility Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd financial flexibility index. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Financial Flexibility Index of 0.85x as of September 2025. Free cash flow of CN¥609.18 Million (operating CF CN¥504.02 Million minus capex CN¥105.16 Million) represents 1% of total liabilities (CN¥719.98 Million). See Chengdu Kanghong Pharmaceuticals Group C free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Financial flexibility index of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. Historical Financial Flexibility Index trend for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Check 002773 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Financial Flexibility Index by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full cash flow conversion analysis, see how efficiently does Chengdu Kanghong Pharmaceuticals Group C generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.74x | CN¥1.77 Billion | CN¥1.50 Billion | CN¥645.22 Million | ▲ +21.1% |
| 2024 | 2.26x | CN¥1.57 Billion | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.5% |
| 2023 | 1.89x | CN¥1.36 Billion | CN¥1.22 Billion | CN¥717.76 Million | ▲ +20.2% |
| 2022 | 1.57x | CN¥1.28 Billion | CN¥925.15 Million | CN¥813.85 Million | ▲ +25.9% |
| 2021 | 1.25x | CN¥1.06 Billion | CN¥494.11 Million | CN¥851.08 Million | ▲ +75.0% |
| 2020 | 0.71x | CN¥890.38 Million | CN¥273.32 Million | CN¥1.25 Billion | ▼ -51.5% |
| 2019 | 1.47x | CN¥1.78 Billion | CN¥812.15 Million | CN¥1.21 Billion | ▲ +102.0% |
| 2018 | 0.73x | CN¥809.33 Million | CN¥350.88 Million | CN¥1.11 Billion | ▼ -29.6% |
| 2017 | 1.04x | CN¥1.08 Billion | CN¥766.86 Million | CN¥1.04 Billion | ▼ -13.1% |
| 2016 | 1.19x | CN¥1.02 Billion | CN¥846.35 Million | CN¥853.27 Million | ▼ -25.0% |
| 2015 | 1.59x | CN¥597.80 Million | CN¥481.97 Million | CN¥376.19 Million | ▲ +37.0% |
| 2014 | 1.16x | CN¥381.65 Million | CN¥291.38 Million | CN¥329.11 Million | ▼ -13.6% |
| 2013 | 1.34x | CN¥410.47 Million | CN¥333.31 Million | CN¥305.69 Million | ▲ +22.5% |
| 2012 | 1.10x | CN¥411.35 Million | CN¥281.84 Million | CN¥375.39 Million | ▲ +20.8% |
| 2011 | 0.91x | CN¥326.11 Million | CN¥168.86 Million | CN¥359.58 Million | ▲ +23.7% |
| 2010 | 0.73x | CN¥268.56 Million | CN¥136.79 Million | CN¥366.21 Million | ▼ -22.0% |
| 2009 | 0.94x | CN¥266.69 Million | CN¥108.42 Million | CN¥283.73 Million | — |